Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

被引:9
作者
Alhudiri, Inas [1 ,2 ]
Nolan, Christopher [1 ]
Ellis, Ian [1 ]
Elzagheid, Adam [2 ]
Green, Andrew [1 ]
Chapman, Caroline [3 ]
机构
[1] Univ Nottingham, Biodiscovery Inst, Fac Med, Nottingham Breast Canc Res Ctr,Breast Pathol Res G, Nottingham, England
[2] Libyan Biotechnol Res Ctr, Genet Engn Dept, Tripoli, Libya
[3] Nottingham Univ Hosp NHS Trust, Eastern Bowel Canc Screening Hub, Nottingham, England
关键词
Breast cancer; Cathepsin D; Immunohistochemistry; Tissue microarray; Prognosis; GROWTH; ACTIVATION; INHIBITOR; ESTROGEN; SURVIVAL; INDEX; RNA;
D O I
10.1007/s10549-024-07293-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. There are conflicting results regarding Cathepsin D significance as prognostic and predictor marker in breast cancer. This study aimed to evaluate the expression and prognostic significance of Cathepsin D in early-stage breast cancer. Methods Expression of Cathepsin D was assessed by immunohistochemical staining of tissue microarrays, in a large well-characterized series of early-stage operable breast cancer (n = 954) from Nottingham Primary Breast Carcinoma Series between the period of 1988 and 1998 who underwent primary surgery. Correlation of Cathepsin D expression with clinicopathological parameters and prognosis was evaluated. Results Cathepsin D expression was positive in 71.2% (679/954) of breast cancer tumours. Positive expression of Cathepsin D was significantly associated with high histological grade (p = 0.007), pleomorphism (p = 0.002), poor Nottingham Prognostic Index (NPI) score (p < 0.002), recurrence (p = 0.005) and distant metastasis (p < 0.0001). Kaplan-Meier analysis showed that Cathepsin D expression was significantly associated with shorter breast cancer-specific survival (p = 0.001), higher risk of recurrence (p = 0.001) and distant metastasis (p < 0.0001). ER-positive tumours expressing Cathepsin D and treated with tamoxifen demonstrated a significantly higher risk of distant metastasis. Conclusion Cathepsin D expression significantly predicts poor prognosis in breast cancer and is associated with variables of poor prognosis and shorter outcome. The strong association of Cathepsin D with aggressive tumour characteristics and poor outcomes warrants further research of its potential as a therapeutic target The results also suggest a possible interaction between Cathepsin D and tamoxifen therapy in ER-positive breast cancer which needs further investigation to elucidate the underlying mechanisms.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 38 条
[1]   High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses [J].
Abd El-Rehim, DM ;
Ball, G ;
Pinder, SE ;
Rakha, E ;
Paish, C ;
Robertson, JFR ;
Macmillan, D ;
Blamey, RW ;
Ellis, IO .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :340-350
[2]   Alteration of cathepsin D trafficking induced by hypoxia and extracellular acidification in MCF-7 breast cancer cells [J].
Achour, Oussama ;
Ashraf, Yahya ;
Bridiau, Nicolas ;
Kacem, Meriem ;
Poupard, Nicolas ;
Bordenave-Juchereau, Stephanie ;
Sannier, Frederic ;
Lamerant-Fayel, Nathalie ;
Kieda, Claudine ;
Liaudet-Coopman, Emmanuelle ;
Piot, Jean-Marie ;
Maugard, Thierry ;
Fruitier-Arnaudin, Ingrid .
BIOCHIMIE, 2016, 121 :123-130
[3]   Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies [J].
Ashraf, Yahya ;
Mansouri, Hanane ;
Laurent-Matha, Valerie ;
Alcaraz, Lindsay B. ;
Roger, Pascal ;
Guiu, Severine ;
Derocq, Danielle ;
Robin, Gautier ;
Michaud, Henri-Alexandre ;
Delpech, Helene ;
Jarlier, Marta ;
Pugniere, Martine ;
Robert, Bruno ;
Puel, Anthony ;
Martin, Lucie ;
Landomiel, Flavie ;
Bourquard, Thomas ;
Achour, Oussama ;
Fruitier-Arnaudin, Ingrid ;
Pichard, Alexandre ;
Deshayes, Emmanuel ;
Turtoi, Andrei ;
Poupon, Anne ;
Simony-Lafontaine, Joelle ;
Boissiere-Michot, Florence ;
Pirot, Nelly ;
Bernex, Florence ;
Jacot, William ;
du Manoir, Stanislas ;
Theillet, Charles ;
Pouget, Jean-Pierre ;
Navarro-Teulon, Isabelle ;
Bonnefoy, Nathalie ;
Pelegrin, Andre ;
Chardes, Thierry ;
Martineau, Pierre ;
Liaudet-Coopman, Emmanuelle .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[4]   CHARACTERIZATION OF THE PROXIMAL ESTROGEN-RESPONSIVE ELEMENT OF HUMAN CATHEPSIN-D GENE [J].
AUGEREAU, P ;
MIRALLES, F ;
CAVAILLES, V ;
GAUDELET, C ;
PARKER, M ;
ROCHEFORT, H .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (06) :693-703
[5]   Immunohistochemical cathepsin-D expression in breast cancer: Correlation with established pathological parameters and survival [J].
Aziz, S ;
Pervez, S ;
Khan, S ;
Kayani, N ;
Rahbar, M .
PATHOLOGY RESEARCH AND PRACTICE, 2001, 197 (08) :551-557
[6]   Cathepsin D-Many functions of one aspartic protease [J].
Benes, Petr ;
Vetvicka, Vaclav ;
Fusek, Martin .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (01) :12-28
[7]   Effect of procathepsin D activation peptide on gene expression of breast cancer cells [J].
Benes, Petr ;
Vashishta, Aruna ;
Saraswat-Ohri, Sujata ;
Fusek, Martin ;
Pospisilova, Sarka ;
Tichy, Boris ;
Vetvicka, Vaclav .
CANCER LETTERS, 2006, 239 (01) :46-54
[8]   The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen [J].
Billgren, AM ;
Rutqvist, LE ;
Johansson, H ;
Hägerström, T ;
Skoog, L .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1374-1380
[9]   Specific oncological contribution of cathepsin D and pS2 in human breast cancer: Their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification [J].
Bolufer, P ;
Torregrosa, MD ;
Gomez, L ;
Munarriz, B ;
Lopez, JA ;
Asins, E ;
Espinoza, S ;
Vera, F ;
Vazquez, C ;
Guillem, V .
CLINICA CHIMICA ACTA, 1996, 247 (1-2) :89-103
[10]   CATHEPSIN D ASSAY IN PRIMARY BREAST-CANCER AND LYMPH-NODES - RELATIONSHIP WITH C-MYC, C-ERB-B-2 AND INT-2 ONCOGENE AMPLIFICATION AND NODE INVASIVENESS [J].
BROUILLET, JP ;
THEILLET, C ;
MAUDELONDE, T ;
DEFRENNE, A ;
SIMONYLAFONTAINE, J ;
SERTOUR, J ;
PUJOL, H ;
JEANTEUR, P ;
ROCHEFORT, H .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) :437-441